WO2026133204 - ENT1 INHIBITORS IN COMBINATION WITH CAR-T CELL THERAPY
National phase entry is expected:
Publication Number
WO/2026/133204
Publication Date
25.06.2026
International Application No.
PCT/IB2025/063078
International Filing Date
17.12.2025
Title **
[English]
ENT1 INHIBITORS IN COMBINATION WITH CAR-T CELL THERAPY
[French]
INHIBITEURS D'ENT1 EN COMBINAISON AVEC UNE THÉRAPIE PAR CELLULES CAR-T
Applicants **
ITEOS BELGIUM SA
Inventors
SANDERS, Theodore
MCGRATH, Yvonne
HOUTHUYS, Erica Joke Kateligne Heleen
Priority Data
63/736,131
19.12.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 6175 | |
| EPO | Filing, Examination, Granting | 155036 | |
| Japan | Filing, Examination, Granting | 5181 | |
| South Korea | Filing, Examination, Granting | 10473 | |
| USA | Filing, Examination, Granting | 79990 |
Total:
256,855
Contact Us
Abstract[English]
Disclosed herein are combinations, methods, and uses comprising administering an ENT1 inhibitor and a CAR-T cell therapy for the treatment of a disease. In some embodiments, the disease is cancer.[French]
Sont divulguées ici des combinaisons, des méthodes et des utilisations comprenant l'administration d'un inhibiteur d'ENT1 et d'une thérapie par cellules CAR-T pour le traitement d'une maladie. Dans certains modes de réalisation, la maladie est un cancer.